Melanie Whittington, Ph.D., Member, Center for Healthcare Economics and Policy Advisory Board, is the Managing Director and Head of the Leerink Center for Pharmacoeconomics where she leads pharmacoeconomic evaluations of in-development and recently approved pharmaceuticals. She is also a Senior Fellow at the Center for the Evaluation of Value and Risk in Health (CEVR) at Tufts Medical Center where she works to develop novel methods for value assessment. She was previously the Director of Health Economics for the Institute for Clinical Economic Review (ICER) where she led the cost-effectiveness analyses and budget impact analyses within ICER reviews. She is a leader in the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and was the recipient of the ISPOR Bernie J. O’Brien New Investigator Award. She has a PhD in Health Services Research with a concentration in Health Economics and Outcomes Research.